Caricamento...
Ruxolitinib for treatment of refractory hemophagocytic lymphohistiocytosis
Optimal salvage therapy for refractory HLH is unknown. In our patient, ruxolitinib treatment led to clinical remission of refractory HLH.
Salvato in:
| Pubblicato in: | Blood Adv |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Society of Hematology
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5728466/ https://ncbi.nlm.nih.gov/pubmed/29296794 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2017007526 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|